GEIS 51

v. 3.0

06-JUL-2021



Phase II multicenter trial of palbociclib in second line of advanced sarcomas with CDK4 overexpression



Supported browsers:
Chrome v.75 or superior
Firefox v.57 or superior
Other browsers are not supported.